SITC Cancer Immunotherapy CONNECT


 

SITC 2018 Abstract Titles
Now Available

Browse the latest research

sitc17-mobile-app-5x5-v2.png

SITC 2018 Mobile App

Download the SITC 2018 Meeting App and get the most out of your 33rd Annual Meeting & Pre-Conference Programs experience.

App_store_2.png google_play41b1436a274e994aa7.png

Learn more

sitc_log_color.png
New FDA and SITC Co-Sponsored Workshop: Immune-modified Response Criteria in Cancer Immunotherapy Clinical Trials

LEARN MORE

sitc_log_color.png

SITC Congratulates 2018 Nobel Laureates James P. Allison, PhD, and Tasuku Honjo, MD, PhD

Read MORE

aci17-cmyk.png
Stay Current with FDA-Approved Immunotherapy Treatments
Attend an upcoming SITC Advances in Cancer Immunotherapy™ Program


IndianapolisMinneapolis | Seattle
New York City | Louisville, Ky. | Pittsburgh

 



sitc-connect-ed-cmyk_FINAL.png

Understand Cancer Immunotherapy With This
Free Online Activity

The Society for Immunotherapy of Cancer’s new online activity explains cancer immunotherapy and the immune system to patients.

Register for the online ACTIVITY

sitc_log_color.png


Join a SITC Professional Interest Community

Create new collaborations, build your professional network and discuss the latest research trends in SITC Professional Interest Communities.

Learn More and Join Today



cig-big.png

JITC Earns Impact Factor of 8.374

 

 The Journal for ImmunoTherapy of Cancer (JITC) received its first impact factor of 8.374! JITC’s impact factor ranks in the top 8 percent of all journals published in the categories of oncology and immunology.

 

LEARN MORE

sitc_log_white.png

Learn the Value of 
SITC MEMBERSHIP!

member-ribbon-v4.pngSee members discuss the benefits of a SITC membership in this new video.

Watch The Video

Patient

Explore resources and educational opportunities for cancer patients and those who advocate for them.

Explore

 

 

 

 

Clinician

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.

Explore

 

 

 

 

Researcher

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.

Explore

 

 

 

 

Latest Discussions

  • Profile Picture

    RE: Hello

    Posted in: Women in SITC

    Welcome Silvia (Dr. Guglietta). Glad that you are here!  Priscila ------------------------------ Priscila Goncalves Associate Director Center for Novel Cancer Therapies Northwell Health - Monter Cancer Center Lake Success, NY ----------------------- ...

  • Profile Picture

    RE: Hello

    Posted in: Women in SITC

    Hi everyone, Excited to be part of this group and hope to share ideas and find collaborations. I am a mucosal Immunologist and I am working at the University of South Carolina. I am interested in cancer of the digestive tract and microbiota. ------------------------------ ...

  • Dear colleagues, Dear participants,   I would like to invite you to attend and participate actively in our   ISOBM (International Society of Oncology and BioMarkers) 2018 CONGRESS, to be held in Hamburg, Germany, on November 24 - 27, 2018. ...

Follow the SITC Twitter Feed.

 

Connect with colleagues at these Upcoming Events.

 


Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.

 

Learn More

 

The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

 

Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

 

Learn More